BioHarvest Sciences Inc. Common Stock (BHST) News
Follow BioHarvest Sciences Inc. Common Stock (BHST) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 6 public stories across 6 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
M
BioHarvest Sciences Cuts FY2026 Sales Guidance to $32M-$33.5M
BioHarvest Sciences lowered its FY2026 sales guidance from $37M-$40M to $32M-$33.5M, versus the $37.461M estimate.
EARNINGS | Nov 12, 2026, 03:03 PM UTC
M
BioHarvest Sciences announces third-quarter results presentation
BioHarvest Sciences announced a presentation of its third-quarter results.
EQUITY | Oct 29, 2026, 12:16 PM UTC
H
BioHarvest Sciences Announces Share Repurchase Program
Vancouver, British Columbia and Rehovot, Israel--(. - September 29, 2026) - BioHarvest Sciences Inc. NASDAQ:BHST TASE:BHST (FSE: 8MV0) ("BioHarvest" or the "Company"), a Botanical Synthesis company developing and manufac
GEOPOLITICS | Sep 29, 2026, 11:01 AM UTC
L
BioHarvest Sciences announces intention to dual list on TASE
BioHarvest Sciences Inc. said it intends to offer its ordinary shares on the Tel Aviv Stock Exchange (TASE). The company listed its existing NASDAQ and FSE share tickers in the announcement.
GEOPOLITICS | Sep 03, 2026, 11:06 AM UTC
L
Q3 Virtual Investor Summit Presentations Now Available On Demand
Q3 Virtual Investor Summit Presentations Now Available On Demand
EQUITY | Aug 31, 2026, 10:15 PM UTC
L
Conference Call: BioHarvest Sciences Lowers FY2026 Sales Guidance from $42.000M-$48.000M to $37.000M-$40.000M vs $42.914M Est
BioHarvest Sciences (NASDAQ: BHST ) lowers FY2026 sales outlook from $42.000 million-$48.000 million to $37.000 million-$40.000 million vs $42.914 million estimate.
EARNINGS | Aug 11, 2026, 08:16 PM UTC